![](/img/cover-not-exists.png)
COMPARE MAJOR BLEEDING RISK AND ASSOCIATED COSTS AMONG NVAF PATIENTS WITH CHA2DS2-VASC SCORE ≥ 3 NEWLY ANTICOAGULATED WITH APIXABAN VERSUS WARFARIN
Deitelzweig, Steven, Gupta, Kiran, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Eaddy, MichaelVolume:
67
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/s0735-1097(16)30877-4
Date:
April, 2016
File:
PDF, 422 KB
english, 2016